Abstract: The present invention relates to fractions of sources and or preparations of human chorionic gonadotropin, such as fractions of human early pregnancy urine, which fractions have anti-HIV activity. The present invention further relates to pharmaceutical compositions comprising such fractions for treating the effects of HIV infection.

Abstract: A highly efficient fast charger for high capacity batteries and methods for fast charging high capacity batteries. The fast charger preferably comprises a rectified AC input of single or preferably three phases, with an optional power factor corrected input, minimally filtered with high frequency, high ripple current capacitors, which is switched with a power switching circuit in the “buck” configuration into an inductor/capacitor output filter. Metallized film capacitors are employed, to minimize the rectified 360 Hertz AC component filtering while providing transient switch protection and ripple current requirements for the buck regulator, to provide a high current fast charger with substantially improved power factor. High power, high frequency switching with minimized output filter size provides a highly filtered DC output. The fast charger is adapted to be constructed in a modular design for simple maintenance.

Abstract: The present invention relates to novel scyphostatin analogues, which distinguish themselves by acting as SMase inhibitors so that they are of therapeutic use for a number of diseases such as a HIV infection, neurodegenerative diseases, inflammatory diseases, apoplexy, ischemia, myocardial infarction or in the case of atherosclerosis.

Abstract: This invention relates to a tire testing device, and in particular to a device for testing the tires of aircraft. The tire testing device includes a pressure sensor and a temperature sensor, allowing the calculation of the effective pressure at a reference temperature, so that the tires can be tested hot or cold. The device also includes an oxygen sensor, so that the oxygen content of the tire can be determined at the same time.

Abstract: A single crystal M*N article, which may be made by a process including the steps of: providing a substrate of material having a crystalline surface which is epitaxially compatible with M*N; depositing a layer of single crystal M*N over the surface of the substrate; and removing the substrate from the layer of single crystal M*N, e.g., with an etching agent which is applied to the substrate to remove same, to yield the layer of single crystal M*N as said single crystal M*N article. The bulk single crystal M*N article is suitable for use as a substrate for the fabrication of microelectronic structures thereon, to produce microelectronic devices comprising bulk single crystal M*N substrates, or precursor structures thereof.

Abstract: LPS preparations, isolated from gram negative bacterial strains that contain at least one mutation in at least one of the htrB and msbB genes, and methods and therapeutics related thereto. The LPS preparations display both LPS antagonist and adjuvant activities.

Abstract: The present invention provides a method of differential display of prokaryotic messages RNA by RTPCR, the method comprising the steps of: adding a first primer mixture to a first nucleic acid sample including a first mixture of mRNA to form a first primer/first nucleic acid sample mixture; adding the first primer mixture to a second nucleic acid sample including a first mixture of mRNA to form a first primer/second nucleic acid sample mixture; incubating the first primer/first nucleic acid sample mixture to produce a first population of cDNA; incubating the first primer/second nucleic acid sample mixture to produce a second population of cDNA; adding a second primer to the first population of cDNA to form a second primer/first population of cDNA mixture; adding the second primer mixture to the second population of cDNA to form a second primer/second population of cDNA mixture; amplifying the second primer/first population of cDNA mixture to produce a third population of cDNA; amplifying the second primer/seco

Abstract: Process for producing formed cellulosic articles, such as fibers, filaments, sheetings, membranes or tubes, comprising a) extruding a solution of cellulose in an aqueous amine oxide, particularly N-methylmorpholine N-oxide, through an extrusion die via an air gap and coagulating the formed article in an aqueous precipitation bath containing amine oxide, and b) passing the formed article through at least one washing stage for removing residual amine oxide from the article, characterized in that the liquor of the precipitation bath in the precipitation stage and/or the washing liquor of the washing stage(s) is treated with ultra-violet radiation. In this manner the formation and growth of coatings, films and slime deposits caused by microorganisms is avoided on parts of the plant which come into contact with said liquors containing the amine oxide.

Abstract: The invention relates to the use of adeno-associated viruses for decreasing the radiotherapy-induced or chemotherapy-induced resistance in patients who suffer from a cancer which is to be treated by radiotherapy or chemotherapy.

Abstract: The present invention relates to peptides of one or more portions of the human chorionic gonadotropin &bgr;-chain as well as methods for treatment of cancer, using human chorionic gonadotropin, employing the &bgr;-chain of human chorionic gonadotropin, peptides containing a sequence of one or more portions of the &bgr;-chain of human chorionic gonadotropin and derivatives and analogues thereof. The invention further relates to fractions of sources and or preparations of human chorionic gonadotropin, such as fractions of human early pregnancy urine, which fractions have anti-cancer activity. The present invention further relates to pharmaceutical compositions for treating cancer.

Abstract: A non-volatile storage cell manufactured in a standard CMOS process in silicon on insulator is described. The cell is manufactured in a standard single polysilicon layer CMOS process applied to silicon on insulator starting substrates. Two versions of the cell are described with distinct mechanisms for writing onto a floating polysilicon layer storage node. The basic cell comprises crossed N- and P- transistors which share a common channel region and a common floating gate over the channel. Current in the channel results in charge injection through the gate oxide and onto the polysilicon gate conductor where it is permanently stored. Since both N and P type transistors are available, charge of both polarities can be injected. Application of a voltage to either of the transistors results in a current or voltage which is used to perform the reading function. Multiple variations of the cell and its operation are also described along with unique applications of the cell.

Abstract: The invention relates to a method for producing a cellulose solution in an aqueous amine oxide, preferably N-methyl-morpholine-N-oxide, for processing to form cellulosed moulded bodies according to the Lyocell method, whereby said solution has an increased thermal stability. Cellulose is suspended in an aqueous amine oxide and the suspension is converted into the cellulose solution. The inventive method is characterised in that the base use of the cellulose used for producing the solution and of the optionally used additives is detected in a dispersion in aqueous amine oxide solution and in that the cellulose solution is formed by adding a base quantity which matches the detected own consumption of the cellulose and optionally the additives. Cellulose solutions having a stability which is essentially independent from the provenance of the used cellulose can he formed.

Abstract: Multiple variations of a variable capacitor or varactor 10 with built-in programmability; exhibiting high quality, Q, factors; manufactured in a standard CMOS process in silicon on insulator. The cell 10 is manufactured in a standard single polysilicon layer CMOS process applied to silicon on insulator 30 starting substrates. The variable capacitor cell 10 combined with a non-volatile mechanism for programming the tuning range of the varactor 10 results in a varactor 10 which can be tuned and adjusted in an on-chip and purely electronic fashion. The basic variable capacitor cell 10 comprises a floating gate MOS variable capacitor, CMOS, in series with a metal to floating gate fixed capacitor CM/FG.

Abstract: The invention provides transgenic animals comprising a lentiviral transgene, such as an HIV transgene. Also within the scope of the invention are cells and eggs from the transgenic animal. Further included are methods for identifying therapeutic compounds for preventing lentiviral infection and treating associated disease (e.g. AIDS).

Abstract: A method for adapting the volume of a collar bag (1) that is partially filled with bulk material, whereby the collar (3) of said bag is formed by two opposite-lying outwardly bent edge strips (5) and two opposite-lying inwardly bent second edge strips (7), to the volume of the bulk material contained in said bag (1). The invention is characterized in that the first edge strips (5) are pulled apart, whereby the wall of the bag is drawn out of the upper unfilled part of the bag over the folded edges (6) and into the collar (3) or the cross-section of the bag is reduced by pressing the opposite-lying larger parts of the wall. The invention also relates to the collar bag (1) and the device to carry out the above-mentioned method.

Abstract: The invention relates to a protecting cap for the head of a screw that is screwed into a constructional part. A body (2:7) is arranged between the protecting cap (1) and the screw head (3) and produces a positive and a non-positive fit therebetween. The protecting cap protects the screw head from mechanical damage, soiling or corrosion.

Abstract: This invention relates to an HBV vector in which functional genes of HBV are at least partially deleted. In addition, this invention concerns a process for producing such an HBV vector as well as cells usable for this purpose.

Abstract: The present invention relates to peptides of one or more portions of the human chorionic gonadotropin &bgr;-chain as well as methods for treatment and prevention of diseases, including HIV infection, using human chorionic gonadotropin, employing the &bgr;-chain of human chorionic gonadotropin, peptides containing a sequence of one or more portions of the &bgr;-chain of human chorionic gonadotropin and derivatives and analogues thereof. The invention further relates to fractions of sources and or preparations of human chorionic gonadotropin, such as fractions of human early pregnancy urine, which fractions have anti-HIV activity. The present invention further relates to pharmaceutical compositions for treating and/or preventing HIV infection.

Abstract: A method and composition for destruction of infectious prion proteins in tissue, by thermal/enzymatic treatment of the tissue with a prion-destructive protease. The method and composition are applicable to treatment of tissue containing or contaminated with prion protein strains associated with transmissible spongiform encephalopathy (TSE) and/or other prion protein-mediated diseases.

Abstract: This invention relates to a remote shut-off valve, and in particular to a valve for the remote shutting-off of a fluid such as a main water supply. The remote shut-off valve comprises a diaphragm valve and a pilot valve which are connected together by way of flexible tubes so that that pilot valve can be located in a desired location remote from the diaphragm valve. Part of the flow channels between the diaphragm valve and the pilot valve, and also the flow channel to the control chamber of the diaphragm valve are located within the body of the diaphragm valve. Quick-release connectors can be provided to connect the flexible tubes to the pilot valve and to the diaphragm valve.